A new clinical trial testing an oral drug for adults with Parkinson’s disease who continue to experience tremor despite being on standard therapies has launched in the U.S. — and is now recruiting in four states. The Phase 2 trial, called Vista PD (NCT07804615), is assessing the safety…

Helping people with Parkinson’s disease stay active while managing everyday mobility risks may help prevent falls, according to a study of clinicians’ and researchers’ perspectives. The study identified empowerment as central to safer mobility. Experts emphasized tailoring strategies to each person’s abilities, circumstances, and goals rather than simply advising…

I’ve been thinking a lot about energy lately, as many of us have, with the high costs of electricity, gasoline, and oil right now. But I am not thinking only about the energy that runs the things in our lives — cars, heat, the very computer you’re reading this on…

A new sleep scoring system could help doctors better track sleep disruptions in people with advanced Parkinson’s disease, a study suggests. Standard monitoring methods often miss unique disruptions in brain activity caused by the disease. By tracking five newly identified stages of abnormal sleep and wakefulness — patterns absent…

Alamar Biosciences and Nightingale Health have partnered with the UK Biobank to launch a study to identify early blood biomarkers for neurodegenerative conditions such as Parkinson’s disease. Called UK Biobank Proteomics for Risk Identification and Signatures of brain health in Midlife, the study will measure hundreds of…